BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
5.72
+0.45 (8.54%)
Jun 6, 2025, 3:09 PM - Market open
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
$797,857
Profits / Employee
-$121,357
Market Cap
18.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BLRX News
- 7 days ago - Why Is Nano-Cap BioLineRx Stock Surging On Friday? - Benzinga
- 7 days ago - BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting - PRNewsWire
- 10 days ago - BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 17 days ago - BioLineRx to Report First Quarter 2025 Results on May 27, 2025 - PRNewsWire
- 2 months ago - BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioLineRx Reports 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - BioLineRx to Report 2024 Annual Results on March 31, 2025 - PRNewsWire